Alector Inc (ALEC)

1.82 -0.03 (-1.62%) USD  |  NASDAQ  |  Dec 26, 16:00
1.82 0.00 (0.00%) After-Hours: 17:25
More

Alector Research and Development Expense (Quarterly): 48.00M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for ALEC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
AbbVie Inc 2.13B
Precision BioSciences Inc 13.08M
Poseida Therapeutics Inc 41.91M
NovaBay Pharmaceuticals Inc 0.004M
Palatin Technologies Inc 5.744M